American Shared Hospital Services (NYSEAMERICAN:AMS) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com began coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a research note issued on Saturday. The firm set a “hold” rating on the stock.

American Shared Hospital Services Stock Performance

NYSEAMERICAN:AMS opened at $3.32 on Friday. American Shared Hospital Services has a 52 week low of $2.16 and a 52 week high of $3.69. The company has a market capitalization of $21.02 million, a P/E ratio of 41.51 and a beta of 0.66. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.98 and a current ratio of 1.98.

American Shared Hospital Services (NYSEAMERICAN:AMS) last announced its earnings results on Tuesday, May 14th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). American Shared Hospital Services had a return on equity of 4.29% and a net margin of 2.50%. The company had revenue of $5.22 million for the quarter, compared to the consensus estimate of $5.01 million. On average, equities research analysts predict that American Shared Hospital Services will post 0.29 earnings per share for the current year.

Institutional Trading of American Shared Hospital Services

An institutional investor recently bought a new position in American Shared Hospital Services stock. Empowered Funds LLC purchased a new stake in American Shared Hospital Services (NYSEAMERICAN:AMS) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned about 0.17% of American Shared Hospital Services as of its most recent SEC filing. 23.16% of the stock is currently owned by institutional investors.

American Shared Hospital Services Company Profile

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.